附近上门

Diagnostic health testing startup has created a telehealth platform that provides an infrastructure for payors, providers and government partners to scale testing in weeks versus months.

Subscribe to the 附近上门 Daily

Co-founder and CEO spoke with me in December about predictions surrounding the volume of COVID-19 testing waning as more people are vaccinated.

One of his other predictions came true already, that the :鈥� How they will reach facilities, who will monitor which person gets what vaccine, and who will keep up with reminders for the second dose. Data shows more than were administered in the U.S. since Dec. 14, according to federal data collected by the .

At the time, San Francisco-based ixLayer had secured an in 2019. Now the company is back with $75 million in an oversubscribed Series A funding.

The round was led by with participation from the lead seed investor , as well as , , , and . This new funding brings ixLayer鈥檚 total funding to just under $78.5 million since being founded in 2018, Sanae said.

鈥淟ast year was the toughest for our team — they were working 12-hour shifts and weekends to support the demand,鈥� he told 附近上门 News. 鈥淟ooking back, we should have raised the round earlier, but realized it was no time to breathe. Things got quiet in December, so we started talking to investors. When reaching out to networks, like (Taneja) at General Catalyst, he immediately understood what we were doing.鈥�

Taneja, managing partner at General Catalyst, said via email that he was introduced to ixLayer by another VC, and from the first meeting with Sanae knew the firm wanted to lead the Series A.

鈥淲e invested because this team is addressing some real challenges in our health care system,鈥� he added. 鈥淏illions of lab tests are ordered every year, and they are farmed out to hundreds of thousands of labs. It’s a highly fragmented system and, as COVID exposed to us all, the overall system is not very scalable or resilient. ixLayer has an ambitious vision for becoming the platform that connects all the key stakeholders — consumers, care professionals and diagnostics labs — to digital transform the diagnostics industry.鈥�

COVID-19 accelerated the adoption and comfort, from both consumers and primary care providers, with using telehealth tools, Sanae said. As a result, up to $250 billion of current health care spend in the U.S. could be virtual, according to a . This potential is also creating demand for ixLayer鈥檚 technical infrastructure to connect the services required for telehealth programs to run efficiently, he added.

The company鈥檚 proprietary technology connects the health testing ecosystem of services, enabling the rapid launch of testing programs while driving patient engagement from home.

鈥淓very health test can be done in a new fashion, but our approach is we solve this for you and partner up with those services depending on state and regulation,鈥� Sanae said.

He said he intends to use the new funding to grow the team to support ixLayer鈥檚 growth. It currently works with 14 enterprise customers and two government contracts. It is running some 1,000 testing programs with 450,000 patients and over 1 million lab tests performed in the past year.

There are more than 260,000 laboratories in the U.S. and prior to COVID, there were 14 billion lab tests done. And while the market is north of $50 million this year, it has the potential to jump to as much as $200 million next year, Sanae said.

鈥淭here is a whole telehealth transformation happening as we speak, and 2021 will be a key year,鈥� he added. 鈥淟ast year was a wake-up year, and 2021 is the reactive year. This is going to be an exciting year because we are now where we thought we would be three years from now. Companies will be coming out strong in diagnostics, and we plan to be one of them.鈥�

Illustration: